# EyeCell EYE PEPTIDE GEL PATCH blog post — 2026-08-09

## Published article

- Slug: `cooling-hydrogel-eyecell-eye-peptide-gel-patch`
- Post id: `cmsm42z8p00003m8obfkabid9`
- English: https://genosys.ae/blog/cooling-hydrogel-eyecell-eye-peptide-gel-patch
- Russian: https://genosys.ae/ru/blog/cooling-hydrogel-eyecell-eye-peptide-gel-patch
- Arabic: https://genosys.ae/ar/blog/cooling-hydrogel-eyecell-eye-peptide-gel-patch
- Product: https://genosys.ae/products/33
- Publishing script: `scripts/create-eyecell-eye-peptide-gel-patch-blog.ts`
- Featured image: `/images/patch/main.jpeg`
- Article images: `/images/patch/s1.jpeg` … `/images/patch/s6.jpeg`

## Editorial approach

Long-form EN/RU/AR post that:

1. Frames under-eye “tiredness” via Mayo Clinic / AAO (bags vs pigment vs shadow).
2. Explains thermo-sensitive hydrogel physics (occlusion + cooling + skin-temp delivery).
3. Lists the current Intertek Formula_up actives with exact verified levels.
4. Keeps Acetyl Hexapeptide-8 honest at **46.5 ppb** (no Botox comparison, no invented %).
5. Documents the registered 20–40 minute protocol and EyeCell routine pairing (17 + 24).

## Product source of truth

- `Registration DOC/Formula_up/Formula-GENOSYS EyeCell EYE PEPTIDE GEL PATCH .pdf`
- `Registration DOC/Artwork/[GENOSYS]EYECELL EYE PEPTIDE GEL PATCH.pdf`

Verified points used in the article:

- Niacinamide **2%**, Adenosine **0.04%**, Acetyl Hexapeptide-8 **0.00000470% (46.5 ppb)**
- Glycerin ~10%, Chondrus crispus extract, calcium lactate, madecassoside, panthenol, allantoin
- Korean functional cosmetic: brightening + wrinkle improvement
- Net WT **101 g / 60 patches / 30 applications**
- Use: under eyes and/or brow bone, **20–40 minutes**, pat residue
- Dermatologically tested; made in Korea (DTS MG)

Legacy `Ingredient lists_old` (2018 Jincostech certificate) was **not** used as the formula source.

## Public sources

- [Mayo Clinic — Bags under eyes](https://www.mayoclinic.org/diseases-conditions/bags-under-eyes/symptoms-causes/syc-20369927)
- [AAO — Bags under the eyes](https://www.aao.org/eye-health/symptoms/bags-under-eyes)
- [IJRTI 2022 — Cosmetic hydrogel under eye patch review](https://www.ijrti.org/papers/IJRTI2208260.pdf)
- [JOCD 2023 — multi-peptide eye serum clinical evidence](https://doi.org/10.1111/jocd.15849) (ingredient-level context only)

## Claim controls

- No invented efficacy percentages for this patch.
- No neuromodulator / Botox equivalence claims.
- Peptide research cited only as category context; concentration disclosed.
- Cosmetic vs medical distinction retained in EN/RU/AR.
- Older 2018 INCI certificate not used when Formula_up disagrees.

## Publishing behavior

Prisma script is idempotent by slug: create on first run; later runs update content and preserve original `publishedAt`.

## Customer-copy cleanup (2026-08-10)

Removed internal language from EN/RU/AR article body and excerpts:

- No Intertek / Formula_up / “2018 ingredient certificate”
- No “registered artwork” / artboard language
- Customer-facing headings now: “What’s inside the formula” (and RU/AR equivalents)

Intertek paths remain only in the script header comment and this session note.
